05.01.02
BioProgress, Boots Execute Third Stage Of Agreement
BioProgress Technology International, Atlanta, GA, has executed stage three of its product development agreement with The Boots Company, a U.K.-based retailer and contract manufacturer of healthcare, cosmetic and toiletry products. The agreement was first executed in October 2000 and proceeded to stage two in November of last year. The aim of the agreement is to develop a range of new consumer products utilizing BioProgress’ XGel™ film system encapsulation technology.
BioProgress Technology International, Atlanta, GA, has executed stage three of its product development agreement with The Boots Company, a U.K.-based retailer and contract manufacturer of healthcare, cosmetic and toiletry products. The agreement was first executed in October 2000 and proceeded to stage two in November of last year. The aim of the agreement is to develop a range of new consumer products utilizing BioProgress’ XGel™ film system encapsulation technology.